High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication

ACS Infectious Diseases

Volumn 1, Issue 8, 2016, Pages 380-387

  Edwards, Megan R ^a   Pietzsch, Colette ^b   Vausselin, Thibaut ^a   Shaw, Megan L ^a   Bukreyev, Alexander ^b   Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

antiviral; Ebola virus; filovirus; high throughput screen; RNA polymerase; translation

Indexed keywords

AZACITIDINE; AZAURIDINE; CANTHARIDIN; CYCLOHEXIMIDE; EMETINE; GEDUNIN; INOSINATE DEHYDROGENASE INHIBITOR; MYCOPHENOLIC ACID; PUROMYCIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC CONCENTRATION; EBOLAVIRUS; HIGH THROUGHPUT SCREENING; MINIGENOME ASSAY; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; SELECTIVITY INDEX; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 84969131730     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.5b00053     Document Type: Article

References (26)

1. Feldmann, H. and Geisbert, T. W. (2011) Ebola haemorrhagic fever Lancet 377, 849-862 10.1016/S0140-6736(10)60667-8
2. Agua-Agum, J., Ariyarajah, A., Aylward, B., Blake, I. M., Brennan, R., Cori, A., Donnelly, C. A., Dorigatti, I., Dye, C., Eckmanns, T., Ferguson, N. M., Formenty, P., Fraser, C., Garcia, E., Garske, T., Hinsley, W., Holmes, D., Hugonnet, S., Iyengar, S., Jombart, T., Krishnan, R., Meijers, S., Mills, H. L., Mohamed, Y., Nedjati-Gilani, G., Newton, E., Nouvellet, P., Pelletier, L., Perkins, D., Riley, S., Sagrado, M., Schnitzler, J., Schumacher, D., Shah, A., Van Kerkhove, M. D., Varsaneux, O., and Wijekoon Kannangarage, N. (2015) West African Ebola epidemic after one year-slowing but not yet under control N. Engl. J. Med. 372, 584-587 10.1056/NEJMc1414992
3. Towner, J. S., Paragas, J., Dover, J. E., Gupta, M., Goldsmith, C. S., Huggins, J. W., and Nichol, S. T. (2005) Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening Virology 332, 20-27 10.1016/j.virol.2004.10.048
4. Ebihara, H., Theriault, S., Neumann, G., Alimonti, J. B., Geisbert, J. B., Hensley, L. E., Groseth, A., Jones, S. M., Geisbert, T. W., Kawaoka, Y., and Feldmann, H. (2007) In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein J. Infect. Dis. 196 (Suppl. 2) S313-S322 10.1086/520590
5. Uebelhoer, L. S., Albarino, C. G., McMullan, L. K., Chakrabarti, A. K., Vincent, J. P., Nichol, S. T., and Towner, J. S. (2014) High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses Antiviral Res. 106, 86-94 10.1016/j.antiviral.2014.03.018
6. Hoenen, T., Groseth, A., Callison, J., Takada, A., and Feldmann, H. (2013) A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals Antiviral Res. 99, 207-213 10.1016/j.antiviral.2013.05.017
7. Madrid, P. B., Chopra, S., Manger, I. D., Gilfillan, L., Keepers, T. R., Shurtleff, A. C., Green, C. E., Iyer, L. V., Dilks, H. H., Davey, R. A., Kolokoltsov, A. A., Carrion, R., Jr., Patterson, J. L., Bavari, S., Panchal, R. G., Warren, T. K., Wells, J. B., Moos, W. H., Burke, R. L., and Tanga, M. J. (2013) A systematic screen of FDA-approved drugs for inhibitors of biological threat agents PLoS One 8 e60579 10.1371/journal.pone.0060579
8. Muhlberger, E., Weik, M., Volchkov, V. E., Klenk, H. D., and Becker, S. (1999) Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems J. Virol. 73, 2333-2342
9. Hoenen, T., Groseth, A., de Kok-Mercado, F., Kuhn, J. H., and Wahl-Jensen, V. (2011) Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses Antiviral Res. 91, 195-208 10.1016/j.antiviral.2011.06.003
10. Jasenosky, L. D., Neumann, G., and Kawaoka, Y. (2010) Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription Antimicrob. Agents Chemother. 54, 3007-3010 10.1128/AAC.00138-10
11. Luthra, P., Ramanan, P., Mire, C. E., Weisend, C., Tsuda, Y., Yen, B., Liu, G., Leung, D. W., Geisbert, T. W., Ebihara, H., Amarasinghe, G. K., and Basler, C. F. (2013) Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome Cell Host Microbe 14, 74-84 10.1016/j.chom.2013.06.010
12. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays J. Biomol. Screening 4, 67-73 10.1177/108705719900400206
13. Grollman, A. P. (1966) Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics Proc. Natl. Acad. Sci. U. S. A. 56, 1867-1874 10.1073/pnas.56.6.1867
14. Nathans, D. (1964) Puromycin Inhibition of Protein Synthesis: Incorporation of Puromycin into Peptide Chains Proc. Natl. Acad. Sci. U. S. A. 51, 585-592 10.1073/pnas.51.4.585
15. Johnson-Thompson, M. and Albury, D. (1988) Azapyrimidine analogues: inhibition of viral DNA synthesis and protein synthesis in SV40 infected BSC-1 cells In Vitro Cell. Dev. Biol. 24, 1114-1120 10.1007/BF02620813
16. Kim, Y. H., Park, E. J., Park, M. H., Badarch, U., Woldemichael, G. M., and Beutler, J. A. (2006) Crinamine from Crinum asiaticum var. japonicum inhibits hypoxia inducible factor-1 activity but not activity of hypoxia inducible factor-2 Biol. Pharm. Bull. 29, 2140-2142 10.1248/bpb.29.2140
17. Honkanen, R. E. (1993) Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A FEBS Lett. 330, 283-286 10.1016/0014-5793(93)80889-3
18. Patwardhan, C. A., Fauq, A., Peterson, L. B., Miller, C., Blagg, B. S., and Chadli, A. (2013) Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis J. Biol. Chem. 288, 7313-7325 10.1074/jbc.M112.427328
19. Ji, Y., Gu, J., Makhov, A. M., Griffith, J. D., and Mitchell, B. S. (2006) Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP J. Biol. Chem. 281, 206-212 10.1074/jbc.M507056200
20. Olschlager, S., Neyts, J., and Gunther, S. (2011) Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus Antiviral Res. 91, 89-93 10.1016/j.antiviral.2011.05.006
21. Martinez, M. J., Volchkova, V. A., Raoul, H., Alazard-Dany, N., Reynard, O., and Volchkov, V. E. (2011) Role of VP30 phosphorylation in the Ebola virus replication cycle J. Infect. Dis. 204 (Suppl. 3) S934-S940 10.1093/infdis/jir320
22. Modrof, J., Muhlberger, E., Klenk, H. D., and Becker, S. (2002) Phosphorylation of VP30 impairs ebola virus transcription J. Biol. Chem. 277, 33099-33104 10.1074/jbc.M203775200
23. Ilinykh, P. A., Tigabu, B., Ivanov, A., Ammosova, T., Obukhov, Y., Garron, T., Kumari, N., Kovalskyy, D., Platonov, M. O., Naumchik, V. S., Freiberg, A. N., Nekhai, S., and Bukreyev, A. (2014) Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription J. Biol. Chem. 289, 22723-22738 10.1074/jbc.M114.575050
24. Smith, D. R., McCarthy, S., Chrovian, A., Olinger, G., Stossel, A., Geisbert, T. W., Hensley, L. E., and Connor, J. H. (2010) Inhibition of heat-shock protein 90 reduces Ebola virus replication Antiviral Res. 87, 187-194 10.1016/j.antiviral.2010.04.015
25. Connor, J. H., McKenzie, M. O., Parks, G. D., and Lyles, D. S. (2007) Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses Virology 362, 109-119 10.1016/j.virol.2006.12.026
26. Shabman, R. S., Jabado, O. J., Mire, C. E., Stockwell, T. B., Edwards, M., Mahajan, M., Geisbert, T. W., and Basler, C. F. (2014) Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells mBio 5 e02011 10.1128/mBio.02011-14